Literature DB >> 6636183

Kinetic profile in blood and brain of the cholinesterase reactivating oxime HI-6 after intravenous administration to the rat.

D A Ligtenstein, S P Kossen.   

Abstract

The kinetic profile of the oxime HI-6, a potent cholinesterase reactivator, after iv administration of 0.1325 mmol/kg (50 mg/kg) to rats is described. The blood concentrations measured over a period of 300 min can be described by a two-compartment open model. Excretion occurred only by the kidney. Approximately 60% was excreted in unmetabolized form. Brain tissue concentrations were significantly above the detection limit of the HPLC analysis procedure even when a correction was made for the amount of HI-6 present in brain blood. The concentration in brain tissue is built up according to a rapid equilibration mechanism. Disappearance of HI-6 from brain occurred slowly compared to the elimination of HI-6 from blood. These findings are discussed in the light of the existing knowledge on the kinetic behavior of polar solutes in the central nervous system. Whether the concentrations of HI-6 built up in the brain are relevant for the therapy of organophosphate intoxications cannot be determined from the experiments described.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6636183     DOI: 10.1016/0041-008x(83)90334-4

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  9 in total

1.  Distribution of the bispyridinium oxime [14C] HI-6 in male and female rats.

Authors:  P M Lundy; B T Hand; B R Broxup; G Yipchuck; M G Hamilton
Journal:  Arch Toxicol       Date:  1990       Impact factor: 5.153

2.  Therapy of organophosphate poisoning in the rat by direct effects of oximes unrelated to ChE reactivation.

Authors:  H P van Helden; J de Lange; R W Busker; B P Melchers
Journal:  Arch Toxicol       Date:  1991       Impact factor: 5.153

3.  A comparison of trimedoxime, obidoxime, pralidoxime and HI-6 in the treatment of oral organophosphorus insecticide poisoning in the rat.

Authors:  M Jokanović; M Maksimović
Journal:  Arch Toxicol       Date:  1995       Impact factor: 5.153

4.  The biodistribution and pharmacokinetics of the oxime acetylcholinesterase reactivator RS194B in guinea pigs.

Authors:  Michael A Malfatti; Heather A Enright; Nicholas A Be; Edward A Kuhn; Saphon Hok; M Windy McNerney; Victoria Lao; Tuan H Nguyen; Felice C Lightstone; Timothy S Carpenter; Brian J Bennion; Carlos A Valdez
Journal:  Chem Biol Interact       Date:  2017-09-21       Impact factor: 5.192

5.  Nanoparticulate transport of oximes over an in vitro blood-brain barrier model.

Authors:  Sylvia Wagner; Jürgen Kufleitner; Anja Zensi; Miriam Dadparvar; Sascha Wien; Judith Bungert; Tikva Vogel; Franz Worek; Jörg Kreuter; Hagen von Briesen
Journal:  PLoS One       Date:  2010-12-03       Impact factor: 3.240

6.  Non-reactivating effects of HI-6 on hippocampal neurotransmission.

Authors:  B P Melchers; A L van der Laaken; R W Busker; P L Bruijnzeel; H P Van Helden
Journal:  Arch Toxicol       Date:  1994       Impact factor: 5.153

7.  HLö 7 dimethanesulfonate, a potent bispyridinium-dioxime against anticholinesterases.

Authors:  P Eyer; I Hagedorn; R Klimmek; P Lippstreu; M Löffler; H Oldiges; U Spöhrer; I Steidl; L Szinicz; F Worek
Journal:  Arch Toxicol       Date:  1992       Impact factor: 5.153

8.  Pharmacokinetics and pharmacodynamics of the oxime HI6 in dogs.

Authors:  R Klimmek; P Eyer
Journal:  Arch Toxicol       Date:  1986-12       Impact factor: 5.153

9.  Comparison of the therapeutic effects and pharmacokinetics of HI-6, HLö-7, HGG-12, HGG-42 and obidoxime following non-reactivatable acetylcholinesterase inhibition in rats.

Authors:  H P van Helden; H J van der Wiel; J J Zijlstra; B P Melchers; R W Busker
Journal:  Arch Toxicol       Date:  1994       Impact factor: 5.153

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.